Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy

Hepatology International

Volumn 7, Issue 1, 2013, Pages 268-273

  Lunia, Manish Kumar ^a   Sharma, Barjesh Chander ^a   Sachdeva, Sanjeev ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Cirrhosis; Hepatic encephalopathy; Orocecal Transit time; Small intestinal bacterial overgrowth

Indexed keywords

GLUCOSE; HYDROGEN; LACTULOSE;

ADULT; ARTICLE; BACTERIAL OVERGROWTH; CHILD TURCOTTE PUGH SCORE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HYDROGEN BREATH TEST; INTESTINE TRANSIT TIME; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OROCECAL TRANSIT TIME; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE; SMALL INTESTINE BACTERIAL OVERGROWTH;

EID: 84875277977     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-012-9360-9     Document Type: Article

References (28)

1. Ferenci P, Lockwood A, Mullen K et al. Hepatic encephalopathy-definition, nomenclature, diagnosis and quantification: final report of the working party at the 11th world congress of gastroenterology, Vienna 1998. Hepatology 2002;35:716-721
2. Dhiman RK, Saraswat VA, Sharma BK et al. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for study of the liver. J Gastroenterol Hepatol 2010;25(6):1029-1041
3. Bustamante J, Rimola A, Ventura PJ et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999;30:890-895
4. Poordad FF. The burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007;25(Suppl 1):3-9
5. Butterworth RF. Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 2011;53(4):1372-1376
6. Butterworth RF. Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci 1992;37:321-327
7. Liu Q, Duan ZP, Ha DK et al. Symbiotic modulation of gut flora: effect on MHE in patients with cirrhosis. Hepatology 2004;39:1441-1449
8. Bauer TM, Schwacha H, Steinbrückner et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 2002;97(9):2364-2370
9. Gupta A, Dhiman RK, Kumari S et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol 2010;53(5):849-855
10. Nagasako CK, de Oliveira Figueiredo MJ, de Souza Almeida JR et al. Investigation of autonomic function and orocecal transit time in patients with nonalcoholic cirrhosis and the potential influence of these factors on disease outcome. J Clin Gastroenterol 2009;43(9):884-889
11. Mittal VV, Sharma BC, Sharma P et al. A randomized controlled trial comparing lactulose, probiotics, and l-ornithine l-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2011;23(8):725-732
12. Dhiman RK, Kurmi R, Thumburu KK et al. Diagnostic and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 2010;55:2381-2390
13. Kircheis G, Wettstein M, Timmermann L et al. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002;35:357-366
14. Romero-Gómez M, Córdoba J, Jover R et al. Value of critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45(4):879-885
15. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of small intestine. Gastroenterology 1988;95:982-988
16. Sarno S, Erasmas LP, Haslbeck M et al. Orocaecal transit, bacterial overgrowth and hydrogen production in diabetes mellitus. Ital J Gastroenterol 1993;25:490-496
17. Lakshmi CP, Ghoshal UC, Kumar S et al. Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction. Dig Dis Sci 2010;55:1142-1148
18. Gunnarsdottir SA, Sadik R, Shev S et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 2003;98:1362-1370
19. Pande C, Kumar A, Sarin SK. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther 2009;29:1273-1281
20. Casafont Morencos F, de las Heras Castaño G, Martín Ramos L et al. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1996;41:552-556
21. Savarino V, Mela GS, Zentilin P et al. Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. Hepatology 1996;25(2):152-157
22. Rimola A, Soto R, Bory F et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984;4(1):53-58
23. Van Thiel DH, Fagiuoli S, Wright HI et al. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment. Hepatology 1994;19:67-71
24. Fleckenstein JF, Frank S, Thuluvath PJ. Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease. Hepatology 1996;23:471-475
25. Thuluvath PJ, Triger DR. Autonomic neuropathy and chronic liver disease. Q J Med 1989;72:737-747
26. Shukla S, Shukla A, Mehboob S et al. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011;33(6):662-671
27. Bajaj JS, Saeian K, Christensen KM et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008;103:1707-1715
28. Madrid AM, Hurtado C, Venegas M et al. Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am J Gastroenterol 2001;96:1251-1255